Paired associative stimulation as a tool to assess plasticity enhancers in chronic stroke

Joshua Silverstein, Mar Cortes, Katherine Zoe Tsagaris, Alejandra Climent, Linda M. Gerber, Clara Oromendia, Pasquale Fonzetti, Rajiv R. Ratan, Tomoko Kitago, Marco Iacoboni, Allan Wu, Bruce Dobkin, Dylan J. Edwards

Research output: Contribution to journalArticle

Abstract

Background and Purpose: The potential for adaptive plasticity in the post-stroke brain is difficult to estimate, as is the demonstration of central nervous system (CNS) target engagement of drugs that show promise in facilitating stroke recovery. We set out to determine if paired associative stimulation (PAS) can be used (a) as an assay of CNS plasticity in patients with chronic stroke, and (b) to demonstrate CNS engagement by memantine, a drug which has potential plasticity-modulating effects for use in motor recovery following stroke. Methods: We examined the effect of PAS in fourteen participants with chronic hemiparetic stroke at five time-points in a within-subjects repeated measures design study: baseline off-drug, and following a week of orally administered memantine at doses of 5, 10, 15, and 20 mg, comprising a total of seventy sessions. Each week, MEP amplitude pre and post-PAS was assessed in the contralesional hemisphere as a marker of enhanced or diminished plasticity. Strength and dexterity were recorded each week to monitor motor-specific clinical status across the study period. Results: We found that MEP amplitude was significantly larger after PAS in baseline sessions off-drug, and responsiveness to PAS in these sessions was associated with increased clinical severity. There was no observed increase in MEP amplitude after PAS with memantine at any dose. Motor threshold (MT), strength, and dexterity remained unchanged during the study. Conclusion: Paired associative stimulation successfully induced corticospinal excitability enhancement in chronic stroke subjects at the group level. However, this response did not occur in all participants, and was associated with increased clinical severity. This could be an important way to stratify patients for future PAS-drug studies. PAS was suppressed by memantine at all doses, regardless of responsiveness to PAS off-drug, indicating CNS engagement.

Original languageEnglish (US)
Article number792
JournalFrontiers in Genetics
Volume10
Issue numberJUL
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Memantine
Stroke
Pharmaceutical Preparations
Central Nervous System
Central Nervous System Agents
Brain

Keywords

  • Memantine
  • Neurorehabilitation
  • Paired associative stimulation
  • Stroke
  • TMS

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Genetics(clinical)

Cite this

Silverstein, J., Cortes, M., Tsagaris, K. Z., Climent, A., Gerber, L. M., Oromendia, C., ... Edwards, D. J. (2019). Paired associative stimulation as a tool to assess plasticity enhancers in chronic stroke. Frontiers in Genetics, 10(JUL), [792]. https://doi.org/10.3389/fnins.2019.00792

Paired associative stimulation as a tool to assess plasticity enhancers in chronic stroke. / Silverstein, Joshua; Cortes, Mar; Tsagaris, Katherine Zoe; Climent, Alejandra; Gerber, Linda M.; Oromendia, Clara; Fonzetti, Pasquale; Ratan, Rajiv R.; Kitago, Tomoko; Iacoboni, Marco; Wu, Allan; Dobkin, Bruce; Edwards, Dylan J.

In: Frontiers in Genetics, Vol. 10, No. JUL, 792, 01.01.2019.

Research output: Contribution to journalArticle

Silverstein, J, Cortes, M, Tsagaris, KZ, Climent, A, Gerber, LM, Oromendia, C, Fonzetti, P, Ratan, RR, Kitago, T, Iacoboni, M, Wu, A, Dobkin, B & Edwards, DJ 2019, 'Paired associative stimulation as a tool to assess plasticity enhancers in chronic stroke', Frontiers in Genetics, vol. 10, no. JUL, 792. https://doi.org/10.3389/fnins.2019.00792
Silverstein J, Cortes M, Tsagaris KZ, Climent A, Gerber LM, Oromendia C et al. Paired associative stimulation as a tool to assess plasticity enhancers in chronic stroke. Frontiers in Genetics. 2019 Jan 1;10(JUL). 792. https://doi.org/10.3389/fnins.2019.00792
Silverstein, Joshua ; Cortes, Mar ; Tsagaris, Katherine Zoe ; Climent, Alejandra ; Gerber, Linda M. ; Oromendia, Clara ; Fonzetti, Pasquale ; Ratan, Rajiv R. ; Kitago, Tomoko ; Iacoboni, Marco ; Wu, Allan ; Dobkin, Bruce ; Edwards, Dylan J. / Paired associative stimulation as a tool to assess plasticity enhancers in chronic stroke. In: Frontiers in Genetics. 2019 ; Vol. 10, No. JUL.
@article{7620aedb0edd4620a609b489d1207125,
title = "Paired associative stimulation as a tool to assess plasticity enhancers in chronic stroke",
abstract = "Background and Purpose: The potential for adaptive plasticity in the post-stroke brain is difficult to estimate, as is the demonstration of central nervous system (CNS) target engagement of drugs that show promise in facilitating stroke recovery. We set out to determine if paired associative stimulation (PAS) can be used (a) as an assay of CNS plasticity in patients with chronic stroke, and (b) to demonstrate CNS engagement by memantine, a drug which has potential plasticity-modulating effects for use in motor recovery following stroke. Methods: We examined the effect of PAS in fourteen participants with chronic hemiparetic stroke at five time-points in a within-subjects repeated measures design study: baseline off-drug, and following a week of orally administered memantine at doses of 5, 10, 15, and 20 mg, comprising a total of seventy sessions. Each week, MEP amplitude pre and post-PAS was assessed in the contralesional hemisphere as a marker of enhanced or diminished plasticity. Strength and dexterity were recorded each week to monitor motor-specific clinical status across the study period. Results: We found that MEP amplitude was significantly larger after PAS in baseline sessions off-drug, and responsiveness to PAS in these sessions was associated with increased clinical severity. There was no observed increase in MEP amplitude after PAS with memantine at any dose. Motor threshold (MT), strength, and dexterity remained unchanged during the study. Conclusion: Paired associative stimulation successfully induced corticospinal excitability enhancement in chronic stroke subjects at the group level. However, this response did not occur in all participants, and was associated with increased clinical severity. This could be an important way to stratify patients for future PAS-drug studies. PAS was suppressed by memantine at all doses, regardless of responsiveness to PAS off-drug, indicating CNS engagement.",
keywords = "Memantine, Neurorehabilitation, Paired associative stimulation, Stroke, TMS",
author = "Joshua Silverstein and Mar Cortes and Tsagaris, {Katherine Zoe} and Alejandra Climent and Gerber, {Linda M.} and Clara Oromendia and Pasquale Fonzetti and Ratan, {Rajiv R.} and Tomoko Kitago and Marco Iacoboni and Allan Wu and Bruce Dobkin and Edwards, {Dylan J.}",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fnins.2019.00792",
language = "English (US)",
volume = "10",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "JUL",

}

TY - JOUR

T1 - Paired associative stimulation as a tool to assess plasticity enhancers in chronic stroke

AU - Silverstein, Joshua

AU - Cortes, Mar

AU - Tsagaris, Katherine Zoe

AU - Climent, Alejandra

AU - Gerber, Linda M.

AU - Oromendia, Clara

AU - Fonzetti, Pasquale

AU - Ratan, Rajiv R.

AU - Kitago, Tomoko

AU - Iacoboni, Marco

AU - Wu, Allan

AU - Dobkin, Bruce

AU - Edwards, Dylan J.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background and Purpose: The potential for adaptive plasticity in the post-stroke brain is difficult to estimate, as is the demonstration of central nervous system (CNS) target engagement of drugs that show promise in facilitating stroke recovery. We set out to determine if paired associative stimulation (PAS) can be used (a) as an assay of CNS plasticity in patients with chronic stroke, and (b) to demonstrate CNS engagement by memantine, a drug which has potential plasticity-modulating effects for use in motor recovery following stroke. Methods: We examined the effect of PAS in fourteen participants with chronic hemiparetic stroke at five time-points in a within-subjects repeated measures design study: baseline off-drug, and following a week of orally administered memantine at doses of 5, 10, 15, and 20 mg, comprising a total of seventy sessions. Each week, MEP amplitude pre and post-PAS was assessed in the contralesional hemisphere as a marker of enhanced or diminished plasticity. Strength and dexterity were recorded each week to monitor motor-specific clinical status across the study period. Results: We found that MEP amplitude was significantly larger after PAS in baseline sessions off-drug, and responsiveness to PAS in these sessions was associated with increased clinical severity. There was no observed increase in MEP amplitude after PAS with memantine at any dose. Motor threshold (MT), strength, and dexterity remained unchanged during the study. Conclusion: Paired associative stimulation successfully induced corticospinal excitability enhancement in chronic stroke subjects at the group level. However, this response did not occur in all participants, and was associated with increased clinical severity. This could be an important way to stratify patients for future PAS-drug studies. PAS was suppressed by memantine at all doses, regardless of responsiveness to PAS off-drug, indicating CNS engagement.

AB - Background and Purpose: The potential for adaptive plasticity in the post-stroke brain is difficult to estimate, as is the demonstration of central nervous system (CNS) target engagement of drugs that show promise in facilitating stroke recovery. We set out to determine if paired associative stimulation (PAS) can be used (a) as an assay of CNS plasticity in patients with chronic stroke, and (b) to demonstrate CNS engagement by memantine, a drug which has potential plasticity-modulating effects for use in motor recovery following stroke. Methods: We examined the effect of PAS in fourteen participants with chronic hemiparetic stroke at five time-points in a within-subjects repeated measures design study: baseline off-drug, and following a week of orally administered memantine at doses of 5, 10, 15, and 20 mg, comprising a total of seventy sessions. Each week, MEP amplitude pre and post-PAS was assessed in the contralesional hemisphere as a marker of enhanced or diminished plasticity. Strength and dexterity were recorded each week to monitor motor-specific clinical status across the study period. Results: We found that MEP amplitude was significantly larger after PAS in baseline sessions off-drug, and responsiveness to PAS in these sessions was associated with increased clinical severity. There was no observed increase in MEP amplitude after PAS with memantine at any dose. Motor threshold (MT), strength, and dexterity remained unchanged during the study. Conclusion: Paired associative stimulation successfully induced corticospinal excitability enhancement in chronic stroke subjects at the group level. However, this response did not occur in all participants, and was associated with increased clinical severity. This could be an important way to stratify patients for future PAS-drug studies. PAS was suppressed by memantine at all doses, regardless of responsiveness to PAS off-drug, indicating CNS engagement.

KW - Memantine

KW - Neurorehabilitation

KW - Paired associative stimulation

KW - Stroke

KW - TMS

UR - http://www.scopus.com/inward/record.url?scp=85070603297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070603297&partnerID=8YFLogxK

U2 - 10.3389/fnins.2019.00792

DO - 10.3389/fnins.2019.00792

M3 - Article

AN - SCOPUS:85070603297

VL - 10

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - JUL

M1 - 792

ER -